About this trial
High-intensity focused ultrasound (HIFU) is an emerging technology that allows for the targeted thermal ablation of deep tissues in a non-invasive manner, by concentrating acoustic energy on the target nerve, whilst preserving adjacent structures. Recently, open clinical studies have confirmed the feasibility, safety and efficacy of HIFU in patients with lumbar facet syndrome, with clinical response rates similar to those of RFA and no significant complications.
This observational, prospective, non-interventional study aims to evaluate the clinical efficacy of lumbar medial branch ablation using this technique at 1, 3 and 6 months, as well as to assess patient satisfaction with the procedure. Only clinical data from patients undergoing the procedure in routine clinical practice will be collected.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Over 18 years of age.
Signed informed consent for data collection.
Mechanical low back pain with a positive diagnostic block (>30% pain reduction) of the lumbar medial ramus with local anaesthetic.
Disqualifiers
Presence of pain with mixed characteristics or suspected multiple aetiology of the low back pain (e.g. sacroiliac joint involvement).
Active systemic infection.
Pregnancy.
History of spinal surgery at the level of treatment.
Trial population
Patients with mechanical low back pain without any other associated clinical features (neuropathic pain characteristics or significant suspicion of pain in other anatomical regions that may be causing the low back pain) who undergo lumbar medial branch ablation using the HIFU technique.
Trial design
Cohort
Prospective
Treatments tested in this trial
High-Intensity Focused Ultrasound of the medial lumbar branch
Procedure/SurgeryFocal exposure, with a duration of 50 seconds and an energy output of 1000 joules. Monitoring of temperature and the patient's response is essential to avoid collateral damage. The objective is to achieve temperatures of 80-85 °C at the focus to induce thermal necrosis of the nerve.
Treatment groups
Trial outcomes
Primary outcomes
Verbal Numerical Rate Scale
0 - 10 Verbal Numerical Rate Scale
Secondary outcomes
Oswestry Scale
Catastrophisme scale
Brief Pain Inventory
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Consorci Sanitari de Terrassa
Lead sponsor
Hospital Clinic of Barcelona
Collaborator
This trial is not recruiting at the moment. You can still explore other options: